BioSpace News Archive

Drug Development

Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)

Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced that a paper detailing the development of its “off-the-shelf” neoantigen platform, SLATE, recently published in Nature Medicine.

April 15, 2024
·
7 min read
Drug Development

Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea & Vomiting at the Upcoming ASPAN 2024 National Conference in Orlando, Florida

Eagle Pharmaceuticals, Inc. announced that data from the Company’s Phase III trial demonstrating the sustained response of amisulpride for the rescue treatment of postoperative nausea and vomiting will be presented at the upcoming American Society of PeriAnesthesia Nurses 2024 National Conference, which is being held April 14-18, 2024, in Orlando, Florida.

April 15, 2024
·
9 min read
Business

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

Viatris Inc. today announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company’s Executive Leadership Team, effective today.

April 15, 2024
·
3 min read
Drug Development

Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)

Longeveron Inc. today announced that it has been accepted for a Featured Research Oral Presentation to present the Company’s CLEAR MIND Phase 2a study results.

April 15, 2024
·
7 min read